Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs Bioverse

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Bioverse head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 474 · Grade C

Bioverse

Visit Bioverse Full brief →

FDA warning letter, September 2025 — issued to Bioverse, Inc. dba Bioverse. See the FDA's warning letter database.

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 52 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make Bioverse a bad call — it's best for readers who can confirm the checkout term, dispensing facility and renewal processing date. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
36
Supply Reliability
95
71
Transparency
90
32
Access Breadth
93
56
Clinical Oversight
92
74
Track Record
88
51
CoreAge RxBrief Score 94 · 52Bioverse

Price, coverage & the tracker

CoreAge RxBioverse
Brief Score94/100 (A)52/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

$129/month equivalent on the advertised six-month prepaid plan.

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

Advertised from $399/month. Confirm the applicable checkout term.

CoverageUS only; restrictions by state, confirmed at intakeConfirm the medication and dispensing pharmacy for your address.
Brand-name accessNot confirmedBioverse lists brand-name medications separately.
Oral / sublingualInjection onlyInjection only
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

Bioverse: Ask which prices and terms apply to the chosen prescription.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.